Cefuroxime 125 mg + Clavulanic Acid 31.25 mg Syrup | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Cefuroxime 125 mg + Clavulanic Acid 31.25 mg Syrup
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Syrup
Class: Second-Gen Cephalosporin + Beta-Lactamase Inhibitor
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Cefuroxime 125 mg + Clavulanic Acid 31.25 mg Syrup Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Cefuroxime 125 mg + Clavulanic Acid 31.25 mg Syrup brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Cefuroxime 125 mg + Clavulanic Acid 31.25 mg Syrup is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Cefuroxime 125 mg + Clavulanic Acid 31.25 mg formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Recurrent paediatric otitis media
- Acute paediatric sinusitis
- Lower respiratory tract infections with beta-lactamase suspicion
- Paediatric pneumonia with prior antibiotic exposure
Mechanism of Action
Cefuroxime is a second-generation cephalosporin that binds penicillin-binding proteins, inhibiting peptidoglycan cross-linking and producing bacterial cell wall destabilisation. Compared with first-generation cephalosporins, cefuroxime has enhanced gram-negative activity (H. influenzae, M. catarrhalis, E. coli) plus retained gram-positive coverage. Clavulanic acid inhibits bacterial beta-lactamases, restoring cefuroxime activity against beta-lactamase-producing strains.
Dosage & Administration
- Children: 25–50 mg/kg/day of cefuroxime in two divided doses for 7–10 days.
- Reconstitute with supplied water;
- refrigerate after reconstitution.
Side Effects
- GI upset (more common with clavulanate), diarrhoea, mild rash.
- Other side effects similar to cefuroxime alone.
Contraindications
- Hypersensitivity to cephalosporins.
- Severe penicillin allergy.
- Caution in renal impairment (dose adjustment).
- Caution in GI disease.
- History of cholestatic jaundice with clavulanate.
Storage
Dry powder below 30 °C. After reconstitution, refrigerate and use within 10 days.
PCD Pharma Franchise for Cefuroxime 125 mg + Clavulanic Acid 31.25 mg Syrup
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 30ml with WFI
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Cefuroxime 125 mg + Clavulanic Acid 31.25 mg Syrup — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Cefuroxime 125 mg + Clavulanic Acid 31.25 mg Syrup, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Cefuroxime 125 mg + Clavulanic Acid 31.25 mg Syrup?
Trumac Healthcare is a WHO-GMP certified manufacturer of Cefuroxime 125 mg + Clavulanic Acid 31.25 mg Syrup in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Cefuroxime 125 mg + Clavulanic Acid 31.25 mg Syrup available for PCD pharma franchise on monopoly basis?
Yes. We offer Cefuroxime 125 mg + Clavulanic Acid 31.25 mg Syrup for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Cefuroxime 125 mg + Clavulanic Acid 31.25 mg Syrup?
Available pack sizes include: 30ml with WFI.
What is the MRP / trade price for Cefuroxime 125 mg + Clavulanic Acid 31.25 mg Syrup?
MRPs range from ₹145 to ₹145 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Cefuroxime 125 mg + Clavulanic Acid 31.25 mg Syrup?